LONDON, Ontario and BOSTON, May 26, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics, (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH), a leading regenerative medicine company focused on developing its ...

NASDAQ:BOLT opened at $0.33 on Tuesday. The company has a current ratio of 3.16, a quick ratio of 3.16 and a debt-to-equity ratio of 0.21. Bolt Biotherapeutics has a 12-month low of $0.29 and a 12 ...

Ratings for Arcutis Biotherapeutics (NASDAQ:ARQT) were provided by 9 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. The following table provides a quick ...

LONDON, Ontario and BOSTON, May 26, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics, (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH), a leading regenerative medicine company focused on developing its Cell ...

Fore Biotherapeutics is seeking another $8 million in late-stage funding. Philadelphia biotechnology firm names former Novartis executive as CEO Philadelphia biotech firm raises $75M; announces ...

WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) between May ...

On May 21, 2025, Sensei Biotherapeutics, Inc. conducted its annual stockholders meeting where three significant proposals were voted upon. With a current market capitalization of $7.55 million and ...

NEW YORK, May 22, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of purchasers of Iovance Biotherapeutics ...